These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 14966260)

  • 21. An analysis of safety and tolerability data from controlled, comparative studies of quetiapine in patients with schizophrenia, focusing on extrapyramidal symptoms.
    Timdahl K; Carlsson A; Stening G
    Hum Psychopharmacol; 2007 Jul; 22(5):315-25. PubMed ID: 17542047
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Quetiapine-associated increase of triglycerides: a case report.
    Zink M; Marquardt L; Sartorius A
    J Clin Psychiatry; 2010 Nov; 71(11):1554-5. PubMed ID: 21114954
    [No Abstract]   [Full Text] [Related]  

  • 23. New-onset diabetic ketoacidosis associated with quetiapine: a case report.
    Sirois F
    Gen Hosp Psychiatry; 2008; 30(6):587-8. PubMed ID: 19061689
    [No Abstract]   [Full Text] [Related]  

  • 24. Efficacy and safety of quetiapine for depressive symptoms in patients with schizophrenia.
    Lee KU; Jeon YW; Lee HK; Jun TY
    Hum Psychopharmacol; 2009 Aug; 24(6):447-52. PubMed ID: 19606454
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Intravenous quetiapine abuse.
    Hussain MZ; Waheed W; Hussain S
    Am J Psychiatry; 2005 Sep; 162(9):1755-6. PubMed ID: 16135642
    [No Abstract]   [Full Text] [Related]  

  • 26. Sexual functioning associated with quetiapine switch vs. risperidone continuation in outpatients with schizophrenia or schizoaffective disorder: a randomized double-blind pilot trial.
    Byerly MJ; Nakonezny PA; Rush AJ
    Psychiatry Res; 2008 May; 159(1-2):115-20. PubMed ID: 18295343
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Thrombotic thrombocytopenic purpura associated with quetiapine.
    Huynh M; Chee K; Lau DH
    Ann Pharmacother; 2005; 39(7-8):1346-8. PubMed ID: 15914516
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Quetiapine: efficacy, tolerability and safety in schizophrenia.
    Miodownik C; Lerner V
    Expert Rev Neurother; 2006 Jul; 6(7):983-92. PubMed ID: 16831113
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Quetiapine-induced erythema multiforme minor: a case report.
    Lin GL; Chiu CH; Lin SK
    J Clin Psychopharmacol; 2006 Dec; 26(6):668-9. PubMed ID: 17110830
    [No Abstract]   [Full Text] [Related]  

  • 30. [The use of Seroquel in schizophrenia].
    Chakhava VO
    Zh Nevrol Psikhiatr Im S S Korsakova; 2000; 100(9):63-4. PubMed ID: 11026140
    [No Abstract]   [Full Text] [Related]  

  • 31. Efficacy of quetiapine for the treatment of schizophrenia: a combined analysis of three placebo-controlled trials.
    Buckley PF
    Curr Med Res Opin; 2004 Sep; 20(9):1357-63. PubMed ID: 15383183
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evaluation of the feasibility of switching from immediate release quetiapine to extended release quetiapine fumarate in stable outpatients with schizophrenia.
    Möller HJ; Johnson S; Mateva T; Brecher M; Svensson O; Miller F; Meulien D;
    Int Clin Psychopharmacol; 2008 Mar; 23(2):95-105. PubMed ID: 18301124
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Abuse of quetiapine. Two addicted patients with borderline personality disorder].
    Galyuk TM; de Backer G; de Jong CA; Beers E; Loonen AJ
    Ned Tijdschr Geneeskd; 2009 Apr; 153(14):674-6. PubMed ID: 19425328
    [No Abstract]   [Full Text] [Related]  

  • 34. Rapid dose initiation of quetiapine for the treatment of acute schizophrenia and schizoaffective disorder: a randomised, multicentre, parallel-group, open study.
    Boidi G; Ferro M
    Hum Psychopharmacol; 2007 Jul; 22(5):299-306. PubMed ID: 17487936
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Priapism associated with quetiapine in an elderly patient].
    Andrés Prado MJ; Vidal Formoso M
    Actas Esp Psiquiatr; 2006; 34(3):209-10. PubMed ID: 16736396
    [No Abstract]   [Full Text] [Related]  

  • 36. Quetiapine-induced insulin resistance after switching from blonanserin despite a loss in both bodyweight and waist circumference.
    Suzuki Y; Sugai T; Fukui N; Watanabe J; Ono S; Tsuneyama N; Saito M; Someya T
    Psychiatry Clin Neurosci; 2012 Oct; 66(6):534-5. PubMed ID: 23066773
    [No Abstract]   [Full Text] [Related]  

  • 37. Rapid remission of severe tardive dyskinesia and tardive dystonia with quetiapine.
    Bouckaert F; Herman G; Peuskens J
    Int J Geriatr Psychiatry; 2005 Mar; 20(3):287-8. PubMed ID: 15770692
    [No Abstract]   [Full Text] [Related]  

  • 38. [An open study on the efficacy and tolerability of quetiapine treatment of patients with schizophrenia].
    Beszłej JA; Grzesiak M
    Psychiatr Pol; 2005; 39(2):293-307. PubMed ID: 15881624
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dose-dependent constipation with higher doses of quetiapine: a case series.
    Raedler TJ; Reimer J; Wiedemann K
    Int Clin Psychopharmacol; 2007 Jul; 22(4):244-6. PubMed ID: 17519649
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Fatal cardiomyopathy due to quetiapine.
    Bush A; Burgess C
    N Z Med J; 2008 Jan; 121(1268):U2909. PubMed ID: 18256721
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.